Analysts at StockNews.com started coverage on shares of Arch Biopartners (NYSE:ARCH – Get Free Report) in a report released on Tuesday. The brokerage set a “hold” rating on the stock.
Arch Biopartners Price Performance
NYSE:ARCH opened at $134.83 on Tuesday. Arch Biopartners has a 52 week low of $116.44 and a 52 week high of $180.65.
Read More
- Five stocks we like better than Arch Biopartners
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- Profitably Trade Stocks at 52-Week Highs
- Are Tariffs Threatening Disney’s Comeback Story?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
